Le Lézard
Classified in: Health
Subject: MRR

Cervical Cancer Diagnostic Global Market Report 2022: Increasing Accuracy of Pap Smear Tests Boosts Industry


DUBLIN, Oct. 6, 2022 /PRNewswire/ -- The "Cervical Cancer Diagnostic Market Size, Share, Trends, By Test Type, By End User, By Therapy, and By Region Forecast to 2030" report has been added to  ResearchAndMarkets.com's offering.

Research and Markets Logo

The global cervical cancer diagnostics market size is expected to reach USD 9,180.63 Million in 2030 and register a revenue CAGR of 5.0% over the forecast period, according to latest report. The growth of this market is driven by the rising prevalence of cervical cancer and government initiatives for early detection of cervical cancer. According to the National Cancer Institute, in 2019, an estimated 13,170 women in the United States will be diagnosed with cervical cancer.

Cervical cancer is caused by human papillomavirus (HPV) infection. HPV is a sexually transmitted infection that can be passed from one person to another through skin-to-skin contact. There are more than 150 types of HPV, and some of these types can lead to cancer.

The most common symptom of cervical cancer is abnormal bleeding from the vagina. Other symptoms include pain during sex, vaginal discharge, and pelvic pain. Cervical cancer is diagnosed through Pap smear test, which is a screening test to detect abnormal cells in the cervix. Treatment for cervical cancer depends on the stage of cancer. The most common treatments are surgery, radiation therapy, and chemotherapy.

The diagnostic test used for cervical cancer is a simple process in which a sample of cervical tissue is taken and examined for the presence of cancer cells. The most common diagnostic tests used for cervical cancer are Pap smear, HPV DNA test, and colposcopy.

Private healthcare companies are focusing on developing new and improved cancer diagnostic technologies to cater to the needs of the rising patient population. For instance, in October 2019, Abbott introduced a new next-generation sequencing-based test for advanced cervical cancer. The test is designed to help clinicians identify patients who may benefit from targeted therapies.

Market Dynamics

Market Drivers

Market Restraints

Market Segmentation

Test Type Outlook (Revenue, USD Billion; 2019-2030)

End-use Outlook (Revenue, USD Billion; 2019-2030)

Therapy Outlook (Revenue, USD Billion; 2019-2030)

Regional Outlook (Revenue, USD Billion; 2019-2030)

Key Topics Covered:

Chapter 1. Market Synopsis

Chapter 2. Executive Summary

Chapter 3. Indicative Metrics

Chapter 4. Cervical Cancer Diagnostic Market Segmentation & Impact Analysis

Chapter 5. Cervical Cancer Diagnostic Market By Test Type Insights & Trends

Chapter 6. Cervical Cancer Diagnostic Market by End-Use Insights & Trends

Chapter 7. Cervical Cancer Diagnostic Market By Therapy Insights & Trends

Chapter 8. Cervical Cancer Diagnostic Market Regional Outlook

Chapter 9. Competitive Landscape

Chapter 10. Company Profiles

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/mi31rs

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]archandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets


These press releases may also interest you

at 02:33
SHANGHAI, Dec. 1, 2022 /PRNewswire/ ? 111, Inc. ("111" or the "Company") , a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited...

at 02:00
BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced that, together with Finland's Euformatics and Hungary's Oncompass Medicine, the BCP-led partnership has now successfully been awarded contract for the...

at 02:00
The teleradiology market size is forecasted to increase by USD 2,804.51 million from 2022 to 2027, at a CAGR of 15.52%, according to the recent market study by Technavio. The growth of the market will be driven by the increasing prevalence of...

at 01:46
Encore Medical Education, a US-based medical education company will launch the 2022 edition of the Best of SABCS® News Highlights program from the 2022 San Antonio Breast Cancer Symposium (SABCS®) starting December 7th. This official SABCS® News...

at 00:29
Cadence Education, LLC. ("Cadence Education"), one of the largest providers of early childhood education in North America, announced that its 2022 annual company-wide fundraising St. Jude Trike-A-Thon event has raised $330,145. This brings Cadence...

at 00:00
This webinar will enable attendees to understand and comply with the FDA's cell and gene therapy...



News published on 6 october 2022 at 12:30 and distributed by: